Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Psychiatry ; 2024 Jan 12.
Article in English | MEDLINE | ID: mdl-38216727

ABSTRACT

Neuroinflammation is a hallmark of Alzheimer's disease (AD) and both positive and negative associations of individual inflammation-related markers with brain structure and cognitive function have been described. We aimed to identify inflammatory signatures of CSF immune-related markers that relate to changes of brain structure and cognition across the clinical spectrum ranging from normal aging to AD. A panel of 16 inflammatory markers, Aß42/40 and p-tau181 were measured in CSF at baseline in the DZNE DELCODE cohort (n = 295); a longitudinal observational study focusing on at-risk stages of AD. Volumetric maps of gray and white matter (GM/WM; n = 261) and white matter hyperintensities (WMHs, n = 249) were derived from baseline MRIs. Cognitive decline (n = 204) and the rate of change in GM volume was measured in subjects with at least 3 visits (n = 175). A principal component analysis on the CSF markers revealed four inflammatory components (PCs). Of these, the first component PC1 (highly loading on sTyro3, sAXL, sTREM2, YKL-40, and C1q) was associated with older age and higher p-tau levels, but with less pathological Aß when controlling for p-tau. PC2 (highly loading on CRP, IL-18, complement factor F/H and C4) was related to male gender, higher body mass index and greater vascular risk. PC1 levels, adjusted for AD markers, were related to higher GM and WM volumes, less WMHs, better baseline memory, and to slower atrophy rates in AD-related areas and less cognitive decline. In contrast, PC2 related to less GM and WM volumes and worse memory at baseline. Similar inflammatory signatures and associations were identified in the independent F.ACE cohort. Our data suggest that there are beneficial and detrimental signatures of inflammatory CSF biomarkers. While higher levels of TAM receptors (sTyro/sAXL) or sTREM2 might reflect a protective glia response to degeneration related to phagocytic clearance, other markers might rather reflect proinflammatory states that have detrimental impact on brain integrity.

2.
Entropy (Basel) ; 25(10)2023 Oct 05.
Article in English | MEDLINE | ID: mdl-37895538

ABSTRACT

Seismic data have improved in quality and quantity over the past few decades, enabling better statistical analysis. Statistical physics has proposed new ways to deal with these data to focus the attention on specific matters. The present paper combines these two progressions to find indicators that can help in the definition of areas where seismic risk is developing. Our data comes from the IPOC catalog for 2007 to 2014. It covers the intense seismic activity near Iquique in Northern Chile during March/April 2014. Centered in these hypocenters we concentrate on the rectangle Lat-22-18 and Lon-68-72 and deepness between 5 and 70 km, where the major earthquakes originate. The analysis was performed using two complementary techniques: Tsallis entropy and mutability (dynamical entropy). Two possible forecasting indicators emerge: (1) Tsallis entropy (mutability) increases (decreases) broadly about two years before the main MW8.1 earthquake. (2) Tsallis entropy (mutability) sharply decreases (increases) a few weeks before the MW8.1 earthquake. The first one is about energy accumulation, and the second one is because of energy relaxation in the parallelepiped of interest. We discuss the implications of these behaviors and project them for possible future studies.

3.
Diabetes ; 66(12): 3098-3104, 2017 12.
Article in English | MEDLINE | ID: mdl-28951388

ABSTRACT

Type 2 diabetes is associated with a high risk of cognitive impairment and dementia. Therefore, strategies are needed to identify patients who are at risk for dementia. Given that the retina is a brain-derived tissue, it may provide a noninvasive way to examine brain pathology. The aims of this study were to evaluate whether retinal sensitivity 1) correlates with the specific parameters of brain imaging related to cognitive impairment and 2) discriminates patients with diabetes with mild cognitive impairment (MCI) from those with normal cognition and those with Alzheimer disease (AD). For this purpose, a prospective, nested case-control study was performed and included 35 patients with type 2 diabetes without cognitive impairment, 35 with MCI, and 35 with AD. Retinal sensitivity was assessed by Macular Integrity Assessment microperimetry, and a neuropsychological evaluation was performed. Brain neurodegeneration was assessed by MRI and fludeoxyglucose-18 positron emission tomography (18FDG-PET). A significant correlation was found between retinal sensitivity and the MRI and 18FDG-PET parameters related to brain neurodegeneration. Retinal sensitivity was related to cognitive status (normocognitive > MCI > AD; P < 0.0001). Our results suggest that retinal sensitivity assessed by microperimetry is related to brain neurodegeneration and could be a useful biomarker for identifying patients with type 2 diabetes who are at risk for developing AD.


Subject(s)
Alzheimer Disease/etiology , Diabetes Mellitus, Type 2/complications , Visual Field Tests , Aged , Aged, 80 and over , Case-Control Studies , Female , Fluorodeoxyglucose F18 , Humans , Magnetic Resonance Imaging , Male , Positron-Emission Tomography , Prospective Studies
4.
J Alzheimers Dis ; 58(4): 1099-1108, 2017.
Article in English | MEDLINE | ID: mdl-28527206

ABSTRACT

BACKGROUND: Different interpretations of cognitive impairment and dementia due to differences in health structures, such as cultural differences could affect the diagnosis and treatment of the condition. it is reasonable to expect that the social and family impact of the disease and coping strategies will differ among societies. OBJECTIVE: The general aim of this study is to understand the social representations of dementia, its associated practices, and the effects they imply. METHODS: People diagnosed with clinical dementia and their families were assessed from 2005 to 2015 in the memory clinic of the Fundació ACE, Institut Català de Neurociències Aplicades in Barcelona, Spain. RESULTS: 9,898 people were examined and 5,792 were diagnosed with dementia. For those with a caregiver (71%), the decision-making fell on the person with dementia in 16.2% of the cases; and for those without a caregiver, in 26.4% of the cases the family did not perceive the deficits as a disease, which led to multiple risk situations (74.6%). CONCLUSIONS: The recognition of dementia as part of aging is common among families. Consequently, risk situations may arise and diagnosis and access to treatment may be delayed. The incorporation of a social appraisal to the diagnostic process is a necessity to evaluate these situations.


Subject(s)
Delivery of Health Care/methods , Dementia/epidemiology , Dementia/therapy , Adaptation, Psychological , Aged , Aged, 80 and over , Ambulatory Care Facilities , Caregivers/psychology , Decision Making/physiology , Dementia/complications , Dementia/psychology , Female , Humans , Male , Memory Disorders/epidemiology , Memory Disorders/etiology , Mental Status and Dementia Tests , Neuropsychological Tests , Retrospective Studies , Spain/epidemiology
5.
J Alzheimers Dis ; 41(3): 739-48, 2014.
Article in English | MEDLINE | ID: mdl-24685632

ABSTRACT

BACKGROUND: There is a range of factors that predict the development of Alzheimer's disease (AD) dementia among patients with amnestic mild cognitive impairment (MCI). OBJECTIVES: To identify the neuropsychological, genetic, and functional brain imaging data that best predict conversion to AD dementia in patients with amnestic MCI. METHODS: From an initial group of 42 amnestic MCI patients assessed with neurological, neuropsychological, and brain SPECT, 39 (25 converters, 14 non-converters) were followed for 4 years, and 36 had APOE ε4 genotyping. Baseline neuropsychological data and brain SPECT data were used to predict which of the MCI patients would develop dementia by the end of the 4 years of observation. RESULTS: The MCI patients who had converted to AD dementia had poorer performance on long-term visual memory and Semantic Fluency tests. The MCI subjects who developed dementia were more likely to carry at least one copy of the APOE ε4 allele (Hazard Risk = 4.22). There was lower brain perfusion in converters than non-converters, mainly in postcentral gyrus. An additional analysis of the SPECT data found differences between the MCI subjects and controls in the posterior cingulate gyrus and the basal forebrain. When the brain imaging and neuropsychological test data were combined in the same Cox regression model, only the neuropsychological test data were significantly associated with time to dementia. CONCLUSION: Although the presence of reduced brain perfusion in postcentral gyrus and basal forebrain indicated an at-risk condition, it was the extent of memory impairment that was linked to the speed of decline from MCI to AD.


Subject(s)
Alzheimer Disease , Apolipoproteins E/genetics , Brain/pathology , Cognitive Dysfunction , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Brain/diagnostic imaging , Cognitive Dysfunction/genetics , Cognitive Dysfunction/pathology , Cognitive Dysfunction/physiopathology , Disease Progression , Female , Functional Laterality , Humans , Incidence , Longitudinal Studies , Magnetic Resonance Imaging , Male , Mental Status Schedule , Middle Aged , Neuropsychological Tests , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...